Select Language:
Despite this progress, insulin still needs to be injected with a needle. This has remained a significant challenge in managing diabetes.
The difficulty stems from the fact that when insulin is swallowed, it passes through the digestive tract where it is rapidly broken down by enzymes designed to digest proteins. Since insulin is a protein, these enzymes destroy much of it before it can do any good.
By the time insulin reaches the intestines, only a small amount remains intact. Additionally, the intestines are not efficient at absorbing insulin into the bloodstream. Due to these obstacles, oral insulin has long been considered more of a “dream” than a practical reality.
A recent study from Kumamoto University in Japan might finally bring this goal closer to reality. Led by Associate Professor Shingo Ito, the research was published in the journal Molecular Pharmaceutics. The team developed a new approach to protect insulin as it travels through the digestive system, allowing it to reach the bloodstream via the intestines.
Their solution involves a special molecule called a cyclic peptide, specifically known as the DNP peptide. This peptide has a unique structure that allows it to pass through the walls of the small intestine more effectively than typical proteins. Using this peptide as a carrier, the researchers devised a way to deliver insulin without injections.
The team tested two different methods of delivering insulin with this system. In the first, they mixed insulin with a modified version of the peptide. This mixture helped keep insulin stable and facilitated its passage through the intestines.
In tests involving diabetic mice, the results were promising. Blood sugar levels quickly returned to normal, and the effects lasted with just one dose per day over several days.
In the second method, the scientists chemically attached the peptide directly to the insulin molecule, creating a new compound that could cross the intestinal lining more efficiently. This approach yielded similar results to the first, confirming that the peptide actively assists insulin in entering the bloodstream.
One of the key findings is that this method doesn’t require extremely large doses. Past efforts to make oral insulin effective often involved super-high doses, which were impractical. In contrast, this new approach achieved approximately 33 to 41 percent of the efficacy of injected insulin—an impressive improvement that could make oral insulin a feasible option.
This breakthrough has the potential to significantly impact people with diabetes. Many patients find daily injections painful and inconvenient, which can diminish their quality of life over time. An oral insulin pill would be much easier to take and might improve treatment adherence.
That said, it’s important to note that this research is still in the early stages. The experiments have only been conducted in animal models, and further research is needed to verify that the method is safe and effective in humans. The scientists are planning to test the system in larger animals that better mimic human physiology.
Overall, these findings represent an exciting advancement. They demonstrate that with innovative technology and creative approaches, longstanding medical challenges can be addressed.
Scientifically, the study is robust because it tested two different delivery methods and produced consistent results. It also tackled one of the biggest barriers in oral medication—poor absorption.
However, since these are early results, human clinical trials will be essential before this method can be used in everyday treatment. If future research confirms these findings, this technology could revolutionize how we treat diabetes worldwide.
For those interested in blood sugar management, consider exploring why blood sugar tends to spike in the mornings or ways to cook sweet potatoes without causing rises in blood glucose.
For brain health insights, check out recent studies about nine unhealthy habits damaging your brain and investigations into how compounds in cannabis might help protect aging brains and treat Alzheimer’s disease.
Source: Kumamoto University.




